Yanyao Gao
1 Xinsi Road
Xi'an, 710038, China
Xi'an, 710038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Reversing zinc dyshomeostasis and oxidative stress: A metallothionein 1-activating MXene/Zn2+ triple-action nanotherapeutic strategy for chronic non-bacterial prostatitis.
Journal: Bioactive materials
Published: July 24, 2025
Spermatocytic tumor associated with metastases: report of a rare case and literature review.
Journal: Frontiers in pharmacology
Published: May 27, 2025
MXene-loaded multifunctional nanoparticles with on-demand controlled antimicrobial and antioxidant capacity for multi-modal treating bacterial prostatitis.
Journal: Biomaterials
Published: January 14, 2025
In situ crosslinked injectable chondroitin sulfate hydrogel for preventing postoperative adhesion.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 08, 2024
HDAC3 improves intestinal function of mice by regulating cGAS-Sting pathway of intestinal glial cells.
Journal: Molecular immunology
Published: May 19, 2023
Hyaluronic acid/serotonin-decorated cerium dioxide nanomedicine for targeted treatment of ulcerative colitis.
Journal: Biomaterials science
Published: December 09, 2022
Hyaluronic acid-modified curcumin-copper complex nano delivery system for rapid healing of bacterial prostatitis.
Journal: Carbohydrate polymers
Published: December 01, 2022
LINC01535 Attenuates ccRCC Progression through Regulation of the miR-146b-5p/TRIM2 Axis and Inactivation of the PI3K/Akt Pathway.
Journal: Journal of oncology
Published: January 10, 2022
Association of finasteride with prostate cancer: A systematic review and meta-analysis.
Journal: Medicine
Published: April 14, 2020
SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.
Journal: Cellular & molecular biology letters
Published: August 12, 2019
Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 24, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026